Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. BriaCell Therapeutics Corp.
  6. Summary
    BCT   CA10778Y3023

BRIACELL THERAPEUTICS CORP.

(BCT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
01/24/2022 01/25/2022 01/26/2022 01/27/2022 01/28/2022 Date
8.1(c) 7.94(c) 7.71(c) 7.87(c) 7.57 Last
27 963 11 372 11 500 13 500 11 111 Volume
-10.00% -1.98% -2.90% +2.08% -3.81% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 - - -
Net income 2022 -12,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -7,41x
Yield 2022 -
Sales 2023 - - -
Net income 2023 -18,2 M - -
Net Debt 2023 - - -
P/E ratio 2023 -5,44x
Yield 2023 -
Capitalization 94,5 M 94,6 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 6
Free-Float 74,2%
More Financials
Company
BriaCell Therapeutics Corp. is a clinical stage immunotherapy company. The Company is focused on developing treatments that boost the ability of the bodyÔÇÖs own cancer-fighting cells to destroy cancerous tumors. Its lead drug candidate, Bria-IMT, is a targeted immunotherapy being developed for the treatment of advanced breast cancer. The Company is focused on conducting Phase I/IIa clinical trial of Bria-IMT in a... 
More about the company
All news about BRIACELL THERAPEUTICS CORP.
01/20BRIACELL THERAPEUTICS : Announces Results of 2022 Annual and Special Meeting of Shareholde..
PU
01/11TMX Group Equity Financing Statistics - December 2021
AQ
01/05BRIACELL THERAPEUTICS : THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF BRIACELL..
PU
2021BRIACELL THERAPEUTICS CORP.(TSXV : BCT) dropped from S&P/TSX Venture Composite Index
CI
2021BRIACELL THERAPEUTICS : to Uplist and Trade on the Toronto Stock Exchange from TSX Venture..
PU
2021BriaCell to List on TSX on Friday
MT
2021BriaCell to Begin Trading on Toronto Stock Exchange
MT
2021BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange un..
AQ
2021BRIACELL THERAPEUTICS : Announces Insiders' Intention to Purchase up to 10% of Public Mark..
PU
2021BriaCell Announces Insiders' Intention to Purchase up to 10% of Public Market Securitie..
AQ
2021BRIACELL THERAPEUTICS : Condensed Interim Consolidated Financial Statements - Form 6-K
PU
2021Tranche Update on BriaCell Therapeutics Corp.'s Equity Buyback Plan announced on Septem..
CI
2021BriaCell Therapeutics Corp. Reports Earnings Results for the First Quarter Ended Octobe..
CI
2021BRIACELL THERAPEUTICS : Investor Presentation
PU
2021BRIACELL THERAPEUTICS : Summarizes Clinical Data Poster Presented at the 2021 San Antonio ..
PU
More news
News in other languages on BRIACELL THERAPEUTICS CORP.
2021BriaCell s'inscrit à la Bourse de Toronto vendredi
2021BriaCell commence à négocier à la Bourse de Toronto
2021BriaCell résume les affiches de données cliniques présentées au symposium sur le cancer..
2021BriaCell ajoute le Mary Crowley Cancer Research Center comme site d'essai clinique pour..
2021BriaCell nomme une vétérante de l'industrie pharmaceutique, Jane Gross, Ph.D., à son co..
More news
Chart BRIACELL THERAPEUTICS CORP.
Duration : Period :
BriaCell Therapeutics Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRIACELL THERAPEUTICS CORP.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 7,57 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
William V. Williams President, Chief Executive Officer & Director
Gadi Levin Chief Financial Officer & Secretary
Jamieson Bondarenko Chairman
Miguel A. Lopez-Lago Senior Director-Research & Development
Rebecca A. Taub Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BRIACELL THERAPEUTICS CORP.-24.69%99
GILEAD SCIENCES, INC.-7.35%84 382
REGENERON PHARMACEUTICALS-4.16%63 645
VERTEX PHARMACEUTICALS3.93%58 082
WUXI APPTEC CO., LTD.-11.62%47 040
BIONTECH SE-40.05%37 325